ADMA News and Press, ADMA Biologics Inc From 05/26/21

RAMSEY, N.J. and BOCA RATON, Fla., May 26, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today announced ...

ADMA delivered another great quarter and is poised to experience revenue growth and margin expansion and has a path to profitability. Despite these positives, ADMA trades near an all-time low and needs cash to continue to finance this growth. ADMA's management may preserve shareho...

Image source: The Motley Fool. ADMA Biologics Inc (NASDAQ: ADMA) Q1 2021 Earnings Call May 12, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: ADMA Biologics Inc (ADMA) Q1 2021 Earnings Call Transcript

ADMA Biologics Inc. (ADMA) Q1 2021 Earnings Conference Call May 12, 2021 4:30 PM ET Company Participants Skyler Bloom - IR Adam Grossman - President and CEO Brian Lenz - CFO Conference Call Participants Anthony Petrone - Jefferies Michael Parolari - Raymond James Presentation Operator Good af...

ADMA Biologics (ADMA) shares rise more than 5% during post-market trading after the company reported first-quarter results that beat Wall Street estimates, helped by the continued commercial ramp of its IVIG product portfolio.The company's total revenue in the quarter grew 57% ...

RAMSEY, N.J. and BOCA RATON, Fla., May 05, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today announced that it...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Motus GI Holdings (NASDAQ: MOTS ) stock is on the rise Friday following clearance from the U.S. Food and Drug Administration (FDA) for one of its medical devices. Source: Shutterstock The medical device from M...

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “ ADMA Biologics Receives FDA Approval for Increased Intravenous Immune Globulin Production Scale ” ADMA Biologics (NASDAQ: ADMA) , Inc. shot ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Today, shares of biopharmaceutical play  ADMA Biologics  (NASDAQ: ADMA ) are on the move in a big way. Investors in ADMA stock are seeing gains of more than 17% at the time of writing on some extremely impress...

Gainers: Brooklyn ImmunoTherapeutics (BTX) +44%.Uxin (UXIN) +25%.Ashford Hospitality Trust (AHT) +24%.Boxlight (BOXL) +21%.ADMA Biologics (ADMA) +18%.Clover Health Investments (CLOV) +16%.Unitil (UTL) +15%.Pitney Bowes (PBI) +15%.ClearSign Technologies (CLIR) +15%.Microvision (MVIS) ...